NETosis in Alzheimer's disease

Frontiers in Immunology

Volumn 8, Issue MAR, 2017, Pages

  Pietronigro, Enrica Caterina ^a   Della Bianca, Vittorina ^a   Zenaro, Elena ^a   Constantin, Gabriela ^a  

^a UNIVERSITY OF VERONA   (Italy)

Author keywords

Alzheimer's disease; Blood brain barrier; Neuroinflammation; Neutrophil extracellular traps; Neutrophils

Indexed keywords

ADENOSINE DIPHOSPHATE; ADVANCED GLYCATION END PRODUCT RECEPTOR; ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN[1-42]; ARACHIDONIC ACID; CATHEPSIN G; CATIONIC ANTIMICROBIAL PROTEIN 37; CD11B ANTIGEN; CD18 ANTIGEN; FIBRINOGEN; G PROTEIN COUPLED RECEPTOR; GELATINASE A; GELATINASE B; HIGH MOBILITY GROUP B1 PROTEIN; HISTONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 8; LEUKOTRIENE B4; MEMBRANE PROTEIN; METALLOPROTEINASE; MYELOPEROXIDASE; PREALBUMIN; PROTEIN ARGININE DEIMINASE; REACTIVE OXYGEN METABOLITE; THROMBIN; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ALZHEIMER DISEASE; AMNESIA; BLOOD BRAIN BARRIER; BLOOD VESSEL; BRAIN NERVE CELL; BRAIN PARENCHYMA; CELL MEMBRANE PERMEABILITY; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; EXTRACELLULAR TRAP; HUMAN; MOLECULAR PATHOLOGY; NERVOUS SYSTEM INFLAMMATION; NEUROFIBRILLARY TANGLE; NEUTROPHIL; NONHUMAN; PARENCHYMA; PROTEIN EXPRESSION; REVIEW; SYNAPSE;

EID: 85017231052     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2017.00211     Document Type: Review

References (139)

1. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol (2013) 13:159-75. doi:10.1038/nri3399
2. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science (2004) 303:1532-5. doi:10.1126/science.1092385
3. Jaillon S, Peri G, Delneste Y, Frémaux I, Doni A, Moalli F, et al. The humoral pattern recognition receptor PTX3 is stored in neutrophil granules and localizes in extracellular traps. J Exp Med (2007) 204:793-804. doi:10.1084/jem.20061301
4. Kessenbrock K, Krumbholz M, Schönermarck U, Back W, Gross WL, Werb Z, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med (2009) 15:623-5. doi:10.1038/nm.1959
5. Papayannopoulos V, Metzler KD, Hakkim A, Zychlinsky A. Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J Cell Biol (2010) 191:677-91. doi:10.1083/jcb.201006052
6. Yipp BG, Petri B, Salina D, Jenne CN, Scott BN, Zbytnuik LD, et al. Infection-induced NETosis is a dynamic process involving neutrophil multitasking in vivo. Nat Med (2012) 18:1386-93. doi:10.1038/nm.2847
7. Garcia-Romo GS, Caielli S, Vega B, Connolly J, Allantaz F, Xu Z, et al. Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med (2011) 3:73ra20. doi:10.1126/scitranslmed.3001201
8. Zenaro E, Pietronigro E, Della Bianca V, Piacentino G, Marongiu L, Budui S, et al. Neutrophils promote Alzheimer's disease-like pathology and cognitive decline via LFA-1 integrin. Nat Med (2015) 21:880-6. doi:10.1038/nm.3913
9. Querfurth HW, LaFerla FM. Alzheimer's disease. N Engl J Med (2010) 362:329-44. doi:10.1056/NEJMra0909142
10. Love S. Contribution of cerebral amyloid angiopathy to Alzheimer's disease. J Neurol Neurosurg Psychiatry (2010) 75:1-4.
11. Wyss-Coray T, Rogers J. Inflammation in Alzheimer disease-a brief review of the basic science and clinical literature. Cold Spring Harb Perspect Med (2012) 2:a006346. doi:10.1101/cshperspect.a006346
12. Heneka MT, Carson MJ, El Khoury J, Landreth GE, Brosseron F, Feinstein DL, et al. Neuroinflammation in Alzheimer's disease. Lancet Neurol (2015) 14:388-405. doi:10.1016/S1474-4422(15)70016-5
13. Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat Rev Neurosci (2015) 16:358-72. doi:10.1038/nrn3880
14. Perry VH, Clive Holmes C. Microglial priming in neurodegenerative disease. Nat Rev Neurol (2014) 10:217-24. doi:10.1038/nrneurol.2014.38
15. in t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med (2001) 345:1515-21. doi:10.1056/NEJMoa010178
16. Szekely CA, Zandi PP. Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence. CNS Neurol Disord Drug Targets (2010) 9:132-9. doi:10.2174/187152710791012026
17. Czirr E, Wyss-Coray T. The immunology of neurodegeneration. J Clin Invest (2012) 122:1156-63. doi:10.1172/JCI58656
18. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci (2006) 7:41-53. doi:10.1038/nrn1824
19. Zlokovic BV. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron (2008) 57:178-201. doi:10.1016/j.neuron.2008.01.003
20. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders. Nat Rev Neurosci (2011) 12:723-38. doi:10.1038/nrn3114
21. Zenaro E, Piacentino G, Constantin G. The blood-brain barrier in Alzheimer's disease. Neurobiol Dis (2016). doi:10.1016/j.nbd.2016.07.007
22. Forman MS, Lal D, Zhang B, Dabir DV, Swanson E, Lee VM, et al. Transgenic mouse model of tau pathology in astrocytes leading to nervous system degeneration. J Neurosci (2005) 25:3539-50. doi:10.1523/JNEUROSCI.0081-05.2005
23. Kovac A, Zilkova M, Deli MA, Zilka N, Novak M. Human truncated tau is using a different mechanism from amyloid-beta to damage the blood-brain barrier. J Alzheimers Dis (2009) 18:897-906. doi:10.3233/JAD-2009-1197
24. Blair LJ, Frauen HD, Zhang B, Nordhues BA, Bijan S, Lin YC, et al. Tau depletion prevents progressive blood-brain barrier damage in a mouse model of tauopathy. Acta Neuropathol Commun (2015) 3:8. doi:10.1186/s40478-015-0186-2
25. Rossi B, Angiari S, Zenaro E, Budui SL, Constantin G. Vascular inflammation in central nervous system diseases: adhesion receptors controlling leukocyte-endothelial interactions. J Leukoc Biol (2011) 89:539-56. doi:10.1189/jlb.0710432
26. Pietronigro E, Zenaro E, Constantin G. Imaging of leukocyte trafficking in Alzheimer's disease. Front Immunol (2016) 7:33. doi:10.3389/fimmu.2016.00033
27. Naert G, Rivest S. CC chemokine receptor 2 deficiency aggravates cognitive impairments and amyloid pathology in a transgenic mouse model of Alzheimer's disease. J Neurosci (2011) 31:6208-20. doi:10.1523/JNEUROSCI.0299-11.2011
28. Prokop S, Miller KR, Drost N, Handrick S, Mathur V, Luo J, et al. Impact of peripheral myeloid cells on amyloid-β pathology in Alzheimer's disease-like mice. J Exp Med (2015) 212:1811-8. doi:10.1084/jem.20150479
29. Varvel NH, Grathwohl SA, Degenhardt K, Resch C, Bosch A, Jucker M, et al. Replacement of brain-resident myeloid cells does not alter cerebral amyloid-β deposition in mouse models of Alzheimer's disease. J Exp Med (2015) 212:1803-9. doi:10.1084/jem.20150478
30. Savage MJ, Iqbal M, Loh T, Trusko SP, Scott R, Siman R. Cathepsin G: localization in human cerebral cortex and generation of amyloidogenic fragments from the beta-amyloid precursor protein. Neuroscience (1994) 60:607-19. doi:10.1016/0306-4522(94)90490-1
31. Pereira HA, Kumar P, Grammas P. Expression of CAP37, a novel inflammatory mediator, in Alzheimer's disease. Neurobiol Aging (1996) 17:753-9. doi:10.1016/0197-4580(96)00118-2
32. Baik SH, Cha MY, Hyun YM, Cho H, Hamza B, Kim DK, et al. Migration of neutrophils targeting amyloid plaques in Alzheimer's disease mouse model. Neurobiol Aging (2014) 35:1286-92. doi:10.1016/j.neurobiolaging.2014.01.003
33. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol (2011) 11:519-31. doi:10.1038/nri3024
34. Caielli S, Banchereau J, Pascual V. Neutrophils come of age in chronic inflammation. Curr Opin Immunol (2012) 24:671-7. doi:10.1016/j.coi.2012.09.008
35. Miller NM, Wang J, Tan Y, Dittel BN. Anti-inflammatory mechanisms of IFN-γ studied in experimental autoimmune encephalomyelitis reveal neutrophils as a potential target in multiple sclerosis. Front Neurosci (2015) 9:287. doi:10.3389/fnins.2015.00287
36. Talukdar S, Oh DY, Bandyopadhyay G, Li D, Xu J, McNelis J, et al. Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase. Nat Med (2012) 18:1407-12. doi:10.1038/nm.2885
37. Chmelar J, Chung KJ, Chavakis T. The role of innate immune cells in obese adipose tissue inflammation and development of insulin resistance. Thromb Haemost (2013) 109:399-406. doi:10.1160/TH12-09-0703
38. Holmin S, Söderlund J, Biberfeld P, Mathiesen T. Intracerebral inflammation after human brain contusion. Neurosurgery (1998) 42:291-8;discussion298-9. doi:10.1097/00006123-199802000-00047
39. Kenne E, Erlandsson A, Lindbom L, Hillered L, Clausen F. Neutrophil depletion reduces edema formation and tissue loss following traumatic brain injury in mice. J Neuroinflammation (2012) 9:17. doi:10.1186/1742-2094-9-17
40. Allen C, Thornton P, Denes A, McColl BW, Pierozynski A, Monestier M, et al. Neutrophil cerebrovascular transmigration triggers rapid neurotoxicity through release of proteases associated with decondensed DNA. J Immunol (2012) 189:381-92. doi:10.4049/jimmunol.1200409
41. Grammas P. A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging (2000) 21:199-205. doi:10.1016/S0197-4580(00)00102-0
42. Brock AJ, Kasus-Jacobi A, Lerner M, Logan S, Adesina AM, Anne Pereira H. The antimicrobial protein, CAP37, is upregulated in pyramidal neurons during Alzheimer's disease. Histochem Cell Biol (2015) 144:293-308. doi:10.1007/s00418-015-1347-x
43. Khandoga A, Huettinger S, Khandoga AG, Li H, Butz S, Jauch KW, et al. Leukocyte transmigration in inflamed liver: a role for endothelial cell-selective adhesion molecule. J Hepatol (2009) 50:755-65. doi:10.1016/j.jhep.2008.11.027
44. Uchida Y, Freitas MC, Zhao D, Busuttil RW, Kupiec-Weglinski JW. The inhibition of neutrophil elastase ameliorates mouse liver damage due to ischemia and reperfusion. Liver Transpl (2009) 15:939-47. doi:10.1002/lt.21770
45. Kuyumcu ME, Yesil Y, Oztürk ZA, Kizilarslanoglu C, Etgül S, Halil M, et al. The evaluation of neutrophil-lymphocyte ratio in Alzheimer's disease. Dement Geriatr Cogn Disord (2012) 34:69-74. doi:10.1159/000341583
46. Shad KF, Aghazadeh Y, Ahmad S, Kress B. Peripheral markers of Alzheimer's disease: surveillance of white blood cells. Synapse (2013) 67:541-3. doi:10.1002/syn.21651
47. Rembach A, Watt AD, Wilson WJ, Rainey-Smith S, Ellis KA, Rowe CC, et al. An increased neutrophil-lymphocyte ratio in Alzheimer's disease is a function of age and is weakly correlated with neocortical amyloid accumulation. J Neuroimmunol (2014) 273:65-71. doi:10.1016/j.jneuroim.2014.05.005
48. Wang X, Li X, Yang J, Yu M, Wu J. Amyloid precursor protein in peripheral granulocytes as a potential biomarker for Alzheimer's disease. Bangladesh J Pharmacol (2016) 11:S92-7. doi:10.3329/bjp.v11iS1.2
49. Järemo P, Milovanovic M, Buller C, Nilsson S, Winblad B. Alzheimer's disease and granulocyte density diversity. Eur J Clin Invest (2013) 43:545-8. doi:10.1111/eci.12072
50. Le Page A, Lamoureux J, Bourgade K, Frost E, Dupuis G, Fulop T. Immune signatures of Alzheimer's disease: profiles of neutrophils (HUM1P.301). J Immunol (2015) 194 (1 Suppl) 52.26.
51. Subramanian S, Ayala P, Wadsworth TL, Harris CJ, Vandenbark AA, Quinn JF, et al. CCR6: a biomarker for Alzheimer's-like disease in a triple transgenic mouse model. J Alzheimers Dis (2010) 22:619-29. doi:10.3233/JAD-2010-100852
52. Tiffany HL, Lavigne MC, Cui YH, Wang JM, Leto TL, Gao JL, et al. Amyloid-beta induces chemotaxis and oxidant stress by acting at formylpeptide receptor 2, a G protein-coupled receptor expressed in phagocytes and brain. J Biol Chem (2001) 276:23645-52. doi:10.1074/jbc.M101031200
53. Phillipson M, Kubes P. The neutrophil in vascular inflammation. Nat Med (2011) 17:1381-90. doi:10.1038/nm.2514
54. Fabene PF, Navarro Mora G, Martinello M, Rossi B, Merigo F, Ottoboni L, et al. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat Med (2008) 14:1377-83. doi:10.1038/nm.1878
55. DiStasi MR, Ley K. Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol (2009) 30:547-56. doi:10.1016/j.it.2009.07.012
56. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med (2007) 13:463-9. doi:10.1038/nm1565
57. Brill A, Fuchs TA, Savchenko AS, Thomas GM, Martinod K, De Meyer SF, et al. Neutrophil extracellular traps promote deep vein thrombosis in mice. J Thromb Haemost (2012) 10:136-44. doi:10.1111/j.1538-7836.2011.04544.x
58. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest (2012) 122:2661-71. doi:10.1172/JCI61303
59. McDonald B, Urrutia R, Yipp BG, Jenne CN, Kubes P. Intravascular neutrophil extracellular traps capture bacteria from the bloodstream during sepsis. Cell Host Microbe (2012) 12:324-33. doi:10.1016/j.chom.2012.06.011
60. Keshari RS, Jyoti A, Dubey M, Kothari N, Kohli M, Bogra J, et al. Cytokines induced neutrophil extracellular traps formation: implication for the inflammatory disease condition. PLoS One (2012) 7:e48111. doi:10.1371/journal.pone.0048111
61. Behnen M, Leschczyk C, Möller S, Batel T, Klinger M, Solbach W, et al. Immobilized immune complexes induce neutrophil extracellular trap release by human neutrophil granulocytes via Fc?RIIIB and Mac-1. J Immunol (2014) 193:1954-65. doi:10.4049/jimmunol.1400478
62. Abram CL, Lowell CA. The ins and outs of leukocyte integrin signaling. Annu Rev Immunol (2009) 27:339-62. doi:10.1146/annurev.immunol.021908.132554
63. Zarbock A, Ley K. Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol (2008) 172:1-7. doi:10.2353/ajpath.2008.070502
64. Neeli I, Dwivedi N, Khan S, Radic M. Regulation of extracellular chromatin release from neutrophils. J Innate Immun (2009) 1:194-201. doi:10.1159/000206974
65. Giri R, Shen Y, Stins M, Du Yan S, Schmidt AM, Stern D, et al. beta-amyloid-induced migration of monocytes across human brain endothelial cells involves RAGE and PECAM-1. Am J Physiol Cell Physiol (2000) 279:C1772-81.
66. Gupta AK, Joshi MB, Philippova M, Erne P, Hasler P, Hahn S, et al. Activated endothelial cells induce neutrophil extracellular traps and are susceptible to NETosis-mediated cell death. FEBS Lett (2010) 584:3193-7. doi:10.1016/j.febslet.2010.06.006
67. Miossec P, Cavender D, Ziff M. Production of interleukin 1 by human endothelial cells. J Immunol (1986) 136:2486-91.
68. Ranta V, Orpana A, Carpén O, Turpeinen U, Ylikorkala O, Viinikka L. Human vascular endothelial cells produce tumor necrosis factor-alpha in response to proinflammatory cytokine stimulation. Crit Care Med (1999) 27:2184-7. doi:10.1097/00003246-199910000-00019
69. Grammas P, Ovase R. Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging (2001) 22:837-42. doi:10.1016/S0197-4580(01)00276-7
70. Grammas P, Samany PG, Thirumangalakudi L. Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis. J Alzheimers Dis (2006) 9:51-8.
71. Yin X, Wright J, Wall T, Grammas P. Brain endothelial cells synthesize neurotoxic thrombin in Alzheimer's disease. Am J Pathol (2010) 176:1600-6. doi:10.2353/ajpath.2010.090406
72. Ueno A, Murakami K, Yamanouchi K, Watanabe M, Kondo T. Thrombin stimulates production of interleukin-8 in human umbilical vein endothelial cells. Immunology (1996) 88:76-81. doi:10.1046/j.1365-2567.1996.d01-635.x
73. Pillitteri D, Bassus S, Boller K, Mahnel R, Scholz T, Westrup D, et al. Thrombin-induced interleukin 1beta synthesis in platelet suspensions: impact of contaminating leukocytes. Platelets (2007) 18:119-27. doi:10.1080/09537100600800792
74. Forlenza OV, Diniz BS, Talib LL, Mendonça VA, Ojopi EB, Gattaz WF, et al. Increased serum IL-1beta level in Alzheimer's disease and mild cognitive impairment. Dement Geriatr Cogn Disord (2009) 28:507-12. doi:10.1159/000255051
75. Alvarez A, Cacabelos R, Sanpedro C, García-Fantini M, Aleixandre M. Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease. Neurobiol Aging (2007) 28:533-6. doi:10.1016/j.neurobiolaging.2006.02.012
76. Zuliani G, Ranzini M, Guerra G, Rossi L, Munari MR, Zurlo A, et al. Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia. J Psychiatr Res (2007) 41:686-93. doi:10.1016/j.jpsychires.2006.02.008
77. Vukic V, Callaghan D, Walker D, Lue LF, Liu QY, Couraud PO, et al. Expression of inflammatory genes induced by beta-amyloid peptides in human brain endothelial cells and in Alzheimer's brain is mediated by the JNK-AP1 signaling pathway. Neurobiol Dis (2009) 34:95-106. doi:10.1016/j.nbd.2008.12.007
78. Askarova S, Yang X, Sheng W, Sun GY, Lee JCM. Role of Aβ-RAGE interaction in oxidative stress and cPLA2 activation in astrocytes and cerebral endothelial cells. Neuroscience (2011) 199:375-85. doi:10.1016/j.neuroscience.2011.09.038
79. Sevush S, Jy W, Horstman LL, Mao WW, Kolodny L, Ahn YS. Platelet activation in Alzheimer disease. Arch Neurol (1998) 55:530-6. doi:10.1001/archneur.55.4.530
80. Jarre A, Gowert NS, Donner L, Münzer P, Klier M, Borst O, et al. Pre-activated blood platelets and a pro-thrombotic phenotype in APP23 mice modeling Alzheimer's disease. Cell Signal (2014) 26:2040-50. doi:10.1016/j.cellsig.2014.05.019
81. Catricala S, Torti M, Ricevuti G. Alzheimer disease and platelets: how's that relevant. Immun Ageing (2012) 9:20. doi:10.1186/1742-4933-9-20
82. Gowert NS, Donner L, Chatterjee M, Eisele YS, Towhid ST, Münzer P, et al. Blood platelets in the progression of Alzheimer's disease. PLoS One (2014) 9:e90523. doi:10.1371/journal.pone.0090523
83. Maugeri N, Campana L, Gavina M, Covino C, De Metrio M, Panciroli C, et al. Activated platelets present high mobility group box 1 to neutrophils, inducing autophagy and promoting the extrusion of neutrophil extracellular traps. J Thromb Haemost (2014) 12:2074-88. doi:10.1111/jth.12710
84. Carestia A, Kaufman T, Rivadeneyra L, Landoni VI, Pozner RG, Negrotto S, et al. Mediators and molecular pathways involved in the regulation of neutrophil extracellular trap formation mediated by activated platelets. J Leukoc Biol (2016) 99:153-62. doi:10.1189/jlb.3A0415-161R
85. Kuijper PH, Gallardo Tores HI, Lammers JW, Sixma JJ, Koenderman L, Zwaginga JJ. Platelet associated fibrinogen and ICAM-2 induce firm adhesion of neutrophils under flow conditions. Thromb Haemost (1998) 80:443-8.
86. Venereau E, Casalgrandi M, Schiraldi M, Antoine DJ, Cattaneo A, De Marchis F, et al. Mutually exclusive redox forms of HMGB1 promote cell recruitment or proinflammatory cytokine release. J Exp Med (2012) 209:1519-28. doi:10.1084/jem.20120189
87. Huebener P, Pradere JP, Hernandez C, Gwak GY, Caviglia JM, Mu X, et al. The HMGB1/RAGE axis triggers neutrophil-mediated injury amplification following necrosis. J Clin Invest (2015) 125:539-50. doi:10.1172/JCI76887
88. Fiuza C, Bustin M, Talwar S, Tropea M, Gerstenberger E, Shelhamer JH, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood (2003) 101:2652-60. doi:10.1182/blood-2002-05-1300
89. Treutiger CJ, Mullins GE, Johansson AS, Rouhiainen A, Rauvala HM, Erlandsson-Harris H, et al. High mobility group 1 B-box mediates activation of human endothelium. J Intern Med (2003) 254:375-85. doi:10.1046/j.1365-2796.2003.01204.x
90. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 5:331-42. doi:10.1038/nri1594
91. Tadie JM, Bae HB, Jiang S, Park DW, Bell CP, Yang H, et al. HMGB1 promotes neutrophil extracellular trap formation through interactions with toll-like receptor 4. Am J Physiol Lung Cell Mol Physiol (2013) 304:L342-9. doi:10.1152/ajplung.00151.2012
92. Fuchs TA, Brill A, Duerschmied D, Schatzberg D, Monestier M, Myers DD Jr, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci U S A (2010) 107:15880-5. doi:10.1073/pnas.1005743107
93. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med (2010) 16:887-96. doi:10.1038/nm.2184
94. Canobbio I, Abubaker AA, Visconte C, Torti M, Pula G. Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease. Front Cell Neurosci (2015) 9:65. doi:10.3389/fncel.2015.00065
95. Akiyama H, Ikeda K, Kondo H, McGeer PL. Thrombin accumulation in brains of patients with Alzheimer's disease. Neurosci Lett (1992) 146:152-4. doi:10.1016/0304-3940(92)90065-F
96. de Boer OJ, Li X, Teeling P, Mackaay C, Ploegmakers HJ, van der Loos CM, et al. Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction. Thromb Haemost (2013) 109:290-7. doi:10.1160/TH12-06-0425
97. Maione F, Cicala C, Liverani E, Mascolo N, Perretti M, D'Acquisto F. IL-17A increases ADP-induced platelet aggregation. Biochem Biophys Res Commun (2011) 408:658-62. doi:10.1016/j.bbrc.2011.04.080
98. Chen JM, Jiang GX, Li QW, Zhou ZM, Cheng Q. Increased serum levels of interleukin-18,-23 and-17 in Chinese patients with Alzheimer's disease. Dement Geriatr Cogn Disord (2014) 38:321-9. doi:10.1159/000360606
99. Deane R, Zlokovic BV. Role of the blood-brain barrier in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res (2007) 4:191-7. doi:10.2174/156720507780362245
100. Rodrigues SF, Granger DN. Blood cells and endothelial barrier function. Tissue Barriers (2015) 3:e978720. doi:10.4161/21688370.2014.978720
101. Carmona-Rivera C, Zhao W, Yalavarthi S, Kaplan MJ. Neutrophil extracellular traps induce endothelial dysfunction in systemic lupus erythematosus through the activation of matrix metalloproteinase-2. Ann Rheum Dis (2015) 74:1417-24. doi:10.1136/annrheumdis-2013-204837
102. Yamaguchi Y, Matsumura F, Wang FS, Akizuki E, Liang J, Matsuda T, et al. Neutrophil elastase enhances intercellular adhesion molecule-1 expression. Transplantation (1998) 65:1622-8. doi:10.1097/00007890-199806270-00014
103. Chaput C, Zychlinsky A. Sepsis: the dark side of histones. Nat Med (2009) 15:1245-6. doi:10.1038/nm1109-1245
104. Saffarzadeh M, Juenemann C, Queisser MA, Lochnit G, Barreto G, Galuska SP, et al. Neutrophil extracellular traps directly induce epithelial and endothelial cell death: a predominant role of histones. PLoS One (2012) 7:e32366. doi:10.1371/journal.pone.0032366
105. Knight JS, Zhao W, Luo W, Subramanian V, O'Dell AA, Yalavarthi S, et al. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest (2013) 123:2981-93. doi:10.1172/JCI67390
106. Knight JS, Subramanian V, O'Dell AA, Yalavarthi S, Zhao W, Smith CK, et al. Peptidylarginine deiminase inhibition disrupts NET formation and protects against kidney, skin and vascular disease in lupus-prone MRL/lpr mice. Ann Rheum Dis (2015) 74:2199-206. doi:10.1136/annrheumdis-2014-205365
107. Kook SY, Hong HS, Moon M, Ha CM, Chang S, Mook-Jung I. Aβ1-42-RAGE interaction disrupts tight junctions of the blood-brain barrier via Ca2+-calcineurin signaling. J Neurosci (2012) 32:8845-54. doi:10.1523/JNEUROSCI.6102-11.2012
108. Wan W, Cao L, Liu L, Zhang C, Kalionis B, Tai X, et al. Aβ(1-42) oligomer-induced leakage in an in vitro blood-brain barrier model is associated with up-regulation of RAGE and metalloproteinases, and down-regulation of tight junction scaffold proteins. J Neurochem (2015) 134:382-93. doi:10.1111/jnc.13122
109. Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol (2010) 10:826-37. doi:10.1038/nri2873
110. Bianca VD, Dusi S, Bianchini E, Dal Prà I, Rossi F. beta-amyloid activates the O-2 forming NADPH oxidase in microglia, monocytes, and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem (1999) 274:15493-9. doi:10.1074/jbc.274.22.15493
111. Azevedo EP, Guimarães-Costa AB, Torezani GS, Braga CA, Palhano FL, Kelly JW, et al. Amyloid fibrils trigger the release of neutrophil extracellular traps (NETs), causing fibril fragmentation by NET-associated elastase. J Biol Chem (2012) 287:37206-18. doi:10.1074/jbc.M112.369942
112. Mitroulis I, Kambas K, Chrysanthopoulou A, Skendros P, Apostolidou E, Kourtzelis I, et al. Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout. PLoS One (2011) 6:e29318. doi:10.1371/journal.pone.0029318
113. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, Yalavarthi S, Knight JS, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med (2013) 5:178ra40. doi:10.1126/scitranslmed.3005580
114. Griffin WS, Stanley LC, Ling C, White L, MacLeod V, Perrot LJ, et al. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A (1989) 86:7611-5. doi:10.1073/pnas.86.19.7611
115. Tarkowski E, Andreasen N, Tarkowski A, Blennow K. Intrathecal inflammation precedes development of Alzheimer's disease. J Neurol Neurosurg Psychiatry (2003) 74:1200-5. doi:10.1136/jnnp.74.9.1200
116. Galimberti D, Fenoglio C, Scarpini E. Inflammation in neurodegenerative disorders: friend or foe? Curr Aging Sci (2008) 1:30-41. doi:10.2174/1874609810801010030
117. Kebir H, Kreymborg K, Ifergan I, Dodelet-Devillers A, Cayrol R, Bernard M, et al. Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation. Nat Med (2007) 13:1173-5. doi:10.1038/nm1651
118. Siffrin V, Radbruch H, Glumm R, Niesner R, Paterka M, Herz J, et al. In vivo imaging of partially reversible th17 cell-induced neuronal dysfunction in the course of encephalomyelitis. Immunity (2010) 33:424-36. doi:10.1016/j.immuni.2010.08.018
119. Achilli C, Ciana A, Minetti G. Amyloid-beta (25-35) peptide induces the release of pro-matrix metalloprotease 9 (pro-MMP-9) from human neutrophils. Mol Cell Biochem (2014) 397:117-23. doi:10.1007/s11010-014-2178-0
120. Peppin GJ, Weiss SJ. Activation of the endogenous metalloproteinase, gelatinase, by triggered human neutrophils. Proc Natl Acad Sci U S A (1986) 83:4322-6. doi:10.1073/pnas.83.12.4322
121. Itoh Y, Nagase H. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem (1995) 270:16518-21. doi:10.1074/jbc.270.28.16518
122. Wang Y, Rosen H, Madtes DK, Shao B, Martin TR, Heinecke JW, et al. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. J Biol Chem (2007) 282:31826-34. doi:10.1074/jbc.M704894200
123. Peress N, Perillo E, Zucker S. Localization of tissue inhibitor of matrix metalloproteinases in Alzheimer's disease and normal brain. J Neuropathol Exp Neurol (1995) 54:16-22. doi:10.1097/00005072-199501000-00002
124. Deb S, Gottschall PE. Increased production of matrix metalloproteinases in enriched astrocyte and mixed hippocampal cultures treated with beta-amyloid peptides. J Neurochem (1996) 66:1641-7. doi:10.1046/j.1471-4159.1996.66041641.x
125. Asahina M, Yoshiyama Y, Hattori T. Expression of matrix metalloproteinase-9 and urinary-type plasminogen activator in Alzheimer's disease brain. Clin Neuropathol (2001) 20:60-3.
126. Nuttall RK, Silva C, Hader W, Bar-Or A, Patel KD, Edwards DR, et al. Metalloproteinases are enriched in microglia compared with leukocytes and they regulate cytokine levels in activated microglia. Glia (2007) 55:516-26. doi:10.1002/glia.20478
127. Mizoguchi H, Takuma K, Fukuzaki E, Ibi D, Someya E, Akazawa KH, et al. Matrix metalloprotease-9 inhibition improves amyloid beta-mediated cognitive impairment and neurotoxicity in mice. J Pharmacol Exp Ther (2009) 331:14-22. doi:10.1124/jpet.109.154724
128. Li P, Li M, Lindberg MR, Kennett MJ, Xiong N, Wang Y. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med (2010) 207:1853-62. doi:10.1084/jem.20100239
129. Allam R, Kumar SV, Darisipudi MN, Anders HJ. Extracellular histones in tissue injury and inflammation. J Mol Med (Berl) (2014) 92:465-72. doi:10.1007/s00109-014-1148-z
130. Chen R, Kang R, Fan XG, Tang D. Release and activity of histone in diseases. Cell Death Dis (2014) 5:e1370. doi:10.1038/cddis.2014.337
131. Gilthorpe JD, Oozeer F, Nash J, Calvo M, Bennett DLH, Lumsden A, et al. Extracellular histone H1 is neurotoxic and drives a pro-inflammatory response in microglia. F1000Research (2013) 2:148. doi:10.12688/f1000research.2-148.v1
132. Issidorides MR, Chrysanthou-Piteroul M, Kriho V, Pappas GD. Histones are components of senile plaques in Alzheimer's disease. Biol Psychiatry (1995) 37:643. doi:10.1016/0006-3223(95)94591-J
133. Duce JA, Smith DP, Blake RE, Crouch PJ, Li QX, Masters CL, et al. Linker histone H1 binds to disease associated amyloid-like fibrils. J Mol Biol (2006) 361:493-505. doi:10.1016/j.jmb.2006.06.038
134. Tillack K, Breiden P, Martin R, Sospedra M. T lymphocyte priming by neutrophil extracellular traps links innate and adaptive immune responses. J Immunol (2012) 188:3150-9. doi:10.4049/jimmunol.1103414
135. Lande R, Ganguly D, Facchinetti V, Frasca L, Conrad C, Gregorio J, et al. Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med (2011) 3:73ra19. doi:10.1126/scitranslmed.3001180
136. Dwivedi N, Upadhyay J, Neeli I, Khan S, Pattanaik D, Myers L, et al. Felty's syndrome autoantibodies bind to deiminated histones and neutrophil extracellular chromatin traps. Arthritis Rheum (2012) 64:982-92. doi:10.1002/art.33432
137. Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, et al. Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease. J Neurosci Res (2005) 80:120-8. doi:10.1002/jnr.20431
138. Barnado A, Crofford LJ, Oates JC. At the bedside: neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in autoimmune diseases. J Leukoc Biol (2016) 99:265-78. doi:10.1189/jlb.5BT0615-234R
139. Knight JS, Luo W, O'Dell AA, Yalavarthi S, Zhao W, Subramanian V, et al. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ Res (2014) 114:947-56. doi:10.1161/CIRCRESAHA.114.303312